---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-242031"
form_type: "8-K"
ticker: "CHRS"
cik: "0001512762"
company_name: "Coherus Oncology, Inc."
filed_at: "2022-09-09T23:59:59+00:00"
generated_at: "2026-06-23T11:54:15.984105+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Coherus appoints Bryan McMichael as Principal Accounting Officer

## Summary
- McMichael, age 44, appointed PAO effective Sept 7, 2022; had been SVP, Accounting and Corporate Controller since March 2021.
- Receives stock option award of 15,000 shares vesting monthly over four years.
- Succeeds McDavid Stilwell, who remains CFO and Principal Financial Officer; transition is planned with no disagreement.

## SEC filing metadata
- accession: 0001193125-22-242031
- form_type: 8-K
- ticker: CHRS
- cik: 0001512762
- company_name: Coherus Oncology, Inc.
- filed_at: 2022-09-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1512762/000119312522242031/0001193125-22-242031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1512762/000119312522242031/d385883d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-242031
- JSON: https://secwatch.observer/filing/0001193125-22-242031.json
- Plain text: https://secwatch.observer/filing/0001193125-22-242031.txt

## Key facts
- Executive change
  Bryan McMichael was appointed as Senior Vice President, Accounting, Corporate Controller and Principal Accounting Officer at Coherus Oncology, Inc..
  - Action: appointed
  - Role: Senior Vice President, Accounting, Corporate Controller and Principal Accounting Officer
  source text: On September 9, 2022, Coherus BioSciences, Inc. (the “Company”) announced the appointment of Bryan McMichael, age 44, as Senior Vice President, Accounting, Corporate Controller and Principal Accounting Officer, effective September 7, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1512762/000119312522242031/0001193125-22-242031-index.htm
- Executive change
  McDavid Stilwell changed role as Principal Accounting Officer at Coherus Oncology, Inc..
  - Action: ceased
  - Role: Principal Accounting Officer
  source text: Mr. Stilwell continues his service to the Company as the Company’s Chief Financial Officer and Principal Financial Officer but will no longer serve as Principal Accounting Officer effective September 7, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1512762/000119312522242031/0001193125-22-242031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.